Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In patients with uremia, increased blood concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) have been linked to the severity of atherosclerosis and to excess cardiovascular mortality. The ADMA levels and several traditional cardiovascular risk factors were assessed in 44 untreated nonsmoking patients with confirmed primary chronic renal disease at different stages of renal disease. True GFR was assessed by means of the inulin-clearance technique. For comparison, nonsmoking subjects matched with respect to age, gender, and body-mass index were examined. Mean plasma ADMA concentration was markedly higher (P < 0.0001) in all patients combined (4.2 +/- 0.9 micromol/L) than in control subjects (n = 16; age 45 +/- 10 yr; serum creatinine 1.0 +/- 0.1 mg/dl; ADMA 1.4 +/- 0.7 micromol/L). However, mean ADMA levels were similar in patients with normal renal function (n = 16; age 41 +/- 9 yr; serum creatinine 1.1 +/- 0.1 mg/dl; GFR 120 +/- 14 ml x min(-1) x 1.73 m2; ADMA 4.0 +/- 0.7 micromol/L), in patients with moderate renal failure (n = 15; 47 +/- 7 yr; 1.8 +/- 0.3 mg/dl; 65 +/- 10 ml x min(-1) x 1.73 m2; 3.8 +/- 0.6 micromol/L) and in patients with advanced renal failure (n = 13; 46 +/- 9 yr; 4.2 +/- 0.9 mg/dl; 25 +/- 4 ml x min(-1) x 1.73 m2; 4.7 +/- 1.2 micromol/L). Furthermore, ADMA levels were increased to the same extent in normotensive (n = 17; 4.0 +/- 0.8 micromol/L) and in hypertensive (n = 27; 4.2 +/- 0.9 micromol/L) patients. In contrast to ADMA, mean total plasma homocysteine concentration were similar in control subjects (10.6 +/- 2.9 micromol/L) and in patients with normal GFR (11.0 +/- 2.9 micromol/L), but were significantly higher in patients with moderate renal failure (17.7 +/- 4.1 micromol/L) and particularly in patients with advanced renal failure (28.2 +/- 10.6 micromol/L). Finally, mean total serum cholesterol concentrations were comparable in the control group and in the three groups of patients with renal disease. In contrast to several traditional cardiovascular risk factors, markedly increased blood concentrations of ADMA, a putative biochemical marker of atherosclerosis, are present even in nonsmoking patients without diabetes with incipient primary renal disease. Thus, the early increase of ADMA levels may be of relevance for the excess cardiovascular morbidity and mortality due to arterio- and atherosclerotic complications in patients with renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,585
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
Suwaidi, J. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,043
Mann, J. F. E., Gerstein, H. C., Pogue, J., Bosch, J., Yusuf, S., & for the HOPE Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00007 · Cited by 1,372
Lemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.179 · Cited by 937
Endogenous Nitric Oxide Synthase Inhibitor: A Novel Marker of Atherosclerosis
Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756
Ito, A., Tsao, P. S., Adimoolam, S., Kimoto, M., Ogawa, T., & Cooke, J. P. (1999) · Circulation · doi:10.1161/01.cir.99.24.3092 · Cited by 631
Does ADMA Cause Endothelial Dysfunction?
Cooke, J. P. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2032 · Cited by 581
Premature cardiovascular disease in chronic renal failure
Baigent, C., Burbury, K., & Wheeler, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02456-9 · Cited by 581
Böger, R. H., Bode-Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490
LEIPER, J. M., MARIA, J. S., Chubb, A., MacAllister, R. J., Charles, I. G., Whitley, G., & Vallance, P. J. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3430209 · Cited by 478
KIELSTEIN, J. T., BÖGER, R. H., BODE-BÖGER, S. M., SCHÄFFER, J., BARBEY, M., KOCH, K. M., & FRÖLICH, J. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103594 · Cited by 361
Self-citationOgawa, T., Kimoto, M., & Sasaoka, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81786-0 · Cited by 360
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
Fliser, D., Pacini, G., Engelleiter, R., Kautzky-Willer, A., Prager, R., Franek, E., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00898.x · Cited by 359
Self-citationAtherosclerosis and arteriosclerosis in chronic renal failure
London, G. M., & Drüeke, T. B. (1997) · Kidney International · doi:10.1038/ki.1997.233 · Cited by 354
Bode-Böger, S. M., Böger, R. H., Kienke, S., Junker, W., & Frölich, J. C. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0279 · Cited by 304
Böger, R. H., Bode-Böger, S. M., Sydow, K., Heistad, D. D., & Lentz, S. R. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1557 · Cited by 278
Cardiovascular Risk Factors in Chronic Renal Failure and Hemodialysis Populations
Ma, K. W., Greene, E. L., & Raij, L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80827-4 · Cited by 269
KRONENBERG, F., KUEN, E., RITZ, E., JUNKER, R., KO[Combining Diaeresis]NIG, P., KRAATZ, G. D., LHOTTA, K., MANN, J. F. E., MU[Combining Diaeresis]LLER, G. A., NEYER, U., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v111105 · Cited by 248
Self-citationEndogenous nitric oxide synthase inhibitors are responsible for the L‐arginine paradox
Tsikas, D., Böger, R. H., Sandmann, J., Bode-Böger, S. M., & Frölich, J. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01686-0 · Cited by 237
Self-citationHyperhomocysteinemia in Chronic Renal Disease
BOSTOM, A. G., & CULLETON, B. F. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104891 · Cited by 237
Renal functional reserve in healthy elderly subjects.
Fliser, D., Zeier, M., Nowack, R., & Ritz, E. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v371371 · Cited by 231
Self-citationIs NO an endogenous antiatherogenic molecule?
Cooke, J. P., & Tsao, P. S. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.653 · Cited by 216
Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure
MacAllister, R. J., Rambausek, M. H., Vallance, P., Williams, D., Hoffmann, K.-H., & Ritz, E. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.12.2449 · Cited by 204
Self-citationTojo, A., Welch, W. J., Bremer, V., Kimoto, M., Kimura, K., Omata, M., Ogawa, T., Vallance, P., & Wilcox, C. S. (1997) · Kidney International · doi:10.1038/ki.1997.490 · Cited by 200
Anderstam, B., Katzarski, K., & Bergström, J. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v891437 · Cited by 168
Pannier, B., Guérin, A. P., Marchais, S. J., Métivier, F., Safar, M. E., & London, G. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00936.x · Cited by 145
Is NO an endogenous antiatherogenic molecule
PCooke, J., & STsao, P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · Cited by 134
Indices of activity of the nitric oxide system in hemodialysis patients
Schmidt, R. J., Domico, J. R., Samsell, L. J., Yokota, S. D., Tracy, T. S., Sorkin, M. I., Engels, K. J., & Baylis, C. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70348-3 · Cited by 116
Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis
Attman, P., Samuelsson, O. G., Moberly, J. B., Johansson, A., Ljungman, S., Weiss, L. G., Knight‐Gibson, C., & Alaupovic, P. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00375.x · Cited by 85
Renal expression of constitutive NOS and DDAH: Separate effects of salt intake and angiotensin
Tojo, A., Kimoto, M., & Wilcox, C. S. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00380.x · Cited by 84
N G , N G -Dimethylarginine and N G , N ' G -dimethylarginine in renal insufficiency
Banchaabouchi, M. A., Marescau, B., Possemiers, I. P., D’Hooge, R., Levillain, O., & Deyn, P. P. D. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050973 · Cited by 83
Gardiner, S. M., Kemp, P. A., Bennett, T., Palmer, R. M. J., & Moncada, S. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13985.x · Cited by 62
Cited by
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Savvidou, M. D., Hingorani, A. D., Tsikas, D., Frölich, J. C., Vallance, P., & Nicolaides, K. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13177-7 · Cited by 514
Nitric oxide deficiency in chronic kidney disease
Baylis, C. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2007 · Cited by 413
Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease
Coca, S. G., Krumholz, H. M., Garg, A. X., & Parikh, C. R. (2006) · JAMA · doi:10.1001/jama.296.11.1377 · Cited by 408
Kielstein, J. T., Impraim, B., Simmel, S., Bode-Böger, S. M., Tsikas, D., Frölich, J. C., Hoeper, M. M., Haller, H., & Fliser, D. (2004) · Circulation · doi:10.1161/01.cir.0000105764.22626.b1 · Cited by 401
Self-citation
Metadata
- Authors
- Kielstein, J. T., Bo[Combining Diaeresis]ger, R. H., Bode-Bo[Combining Diaeresis]ger, S. M., Fro[Combining Diaeresis]lich, J. D. C., Haller, H., Ritz, E., & Fliser, D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2002-01
- Volume
- 13
- Issue
- 1
- Pages
- 170-176
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2124279221
- Cited by
- 369
- References
- 33
- FWCI
- 13.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.